Fast Facts

Small Steps that Lead to the Next Giant Leap in Healthcare Innovation

The Weldon School of Biomedical Engineering is a leading biomedical engineering enterprise with recognized education and translational research programs. The School fosters strong academic, industrial, and clinical ties that create a dynamic and uniquely productive environment for experiential learning and technology development. The Weldon School is solving an expanded set of healthcare problems and improving the lives of patients worldwide.

State-of-the-Art Facility and Endowment

  • $25M, 91,000 gsf Martin C. Jischke Hall of Biomedical Engineering
  • $18M, 30,000 gsf Innovation Wing expansion
  • $10M endowment from Weldon family created first named engineering school at Purdue

Engineering Educational Programs

  • 600+ undergraduates in ABET-accredited program
  • 145+ doctoral students and 80+ Masters students
  • 75% of undergraduates participate in industrial (co-op or internship) or international (study abroad) experiences
  • Robust programs for industry-minded students including online degree programs
  • Professional Masters Program includes Regulatory Affairs and Regulatory Science Certificate
  • More than 1,898 alumnae/alumni

Dynamic and Growing Faculty

  • 37+ core faculty members
  • 25% of faculty are women
  • Growing in strategic areas, especially in Indianapolis
  • 14 NSF CAREER awardees and 11 AIMBE fellows
  • Recognized by NIH Pathfinder, MIRA and PECASE Awardees
  • National Academy of Inventors (NAI) fellows
  • 2 Fulbright Scholars
  • Defense Advanced Research Projects Agency (DARPA) Young Faculty Award (YFA)

Transformative Research and Innovation

  • >$20M in total annual research awards; 25% from industry
  • Federal research funding doubled over past 7 years
  • 22+ postdoctoral fellows; 15 full-time research staff
  • Numerous applied research partnerships including Cook Medical, Eli Lilly, and OrthoPediatrics
  • Main site for Emergent Mechanisms in Biology of Robustness, Integration & Organization (EMBRIO) Institute sponsored by the National Science Foundation (NSF)

Technology Transfer and Entrepreneurship

  • 269+ U.S. patents, over half licensed to company partners (FY12-FY25)
  • $35M+ licensing royalties over the past two decades
  • 36+ companies started, (FY12-25); $75M+ venture capital raised
  • More than 100 million patients worldwide directly helped

Clinical Translation

  • NIGMS-funded Medical Science Training Program (MSTP) with Indiana University School of Medicine
  • 25 physician engineers (MD-PhD BME) trained to date; 19 currently in training
  • Active translational component of NIH-supported Indiana Clinical and Translational Sciences Institute
  • Partnering with IUSM for the Biomedical Engineering and Applied Medical Technology Scholarly Concentration
  • Founding member of Crossroads Pediatric Device Consortium with Riley Hospital for Children, Cook Medical and OrthPediatrics